title: No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomas.
authors.forename: S
authors.initials: S
authors.lastname: Ménard
authors.forename: P
authors.initials: P
authors.lastname: Casalini
authors.forename: S
authors.initials: S
authors.lastname: Pilotti
authors.forename: N
authors.initials: N
authors.lastname: Cascinelli
authors.forename: F
authors.initials: F
authors.lastname: Rilke
authors.forename: M I
authors.initials: MI
authors.lastname: Colnaghi
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000401:mortality* / Q000473:pathology; D005260:Female; D018734:Genes, erbB-2 / Q000235:genetics*; D016158:Genes, p53 / Q000235:genetics*; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis; D009154:Mutation; D009367:Neoplasm Staging; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*; D016019:Survival Analysis; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D016159:Tumor Suppressor Protein p53